These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1615140)

  • 1. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.
    Gray NS; Pickering AD; Hemsley DR; Dawling S; Gray JA
    Psychopharmacology (Berl); 1992; 107(2-3):425-30. PubMed ID: 1615140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.
    Killcross AS; Robbins TW
    Psychopharmacology (Berl); 1993; 110(4):479-89. PubMed ID: 7870920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans.
    Salgado JV; Hetem LA; Vidal M; Graeff FG; Danion JM; Sandner G
    Behav Brain Res; 2000 Dec; 117(1-2):61-7. PubMed ID: 11099758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition.
    Konstandi M; Kafetzopoulos E
    Pharmacol Biochem Behav; 1993 Apr; 44(4):751-4. PubMed ID: 8469686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of latent inhibition by acute administration of low doses of amphetamine.
    Weiner I; Lubow RE; Feldon J
    Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibition.
    McAllister KH
    Psychopharmacology (Berl); 1997 Mar; 130(2):79-84. PubMed ID: 9106903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated.
    Weiner I; Tarrasch R; Bernasconi E; Broersen LM; Rüttimann TC; Feldon J
    Pharmacol Biochem Behav; 1997 Apr; 56(4):817-26. PubMed ID: 9130310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers.
    Kumari V; Cotter PA; Mulligan OF; Checkley SA; Gray NS; Hemsley DR; Thornton JC; Corr PJ; Toone BK; Gray JA
    J Psychopharmacol; 1999 Dec; 13(4):398-405. PubMed ID: 10667617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.
    Killcross AS; Dickinson A; Robbins TW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):185-95. PubMed ID: 7862894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned suppression of an operant response using d-amphetamine as the conditioned stimulus.
    Turner EG; Altshuler HL
    Psychopharmacology (Berl); 1976 Nov; 50(2):139-43. PubMed ID: 826953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine.
    Harmer CJ; Phillips GD
    Neuroscience; 1999 Apr; 90(1):119-30. PubMed ID: 10188939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.
    Joseph MH; Peters SL; Gray JA
    Psychopharmacology (Berl); 1993; 110(1-2):187-92. PubMed ID: 7870882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the stimulus effects of morphine by d-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C; Bacchi A; Babbini M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):249-53. PubMed ID: 9443562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neuroleptic-like effect of ceronapril on latent inhibition.
    Weiner I; Smith AD; Rawlins JN; Feldon J
    Neuroscience; 1992 Jul; 49(2):307-15. PubMed ID: 1359453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kamin blocking is not disrupted by amphetamine in human subjects.
    Gray NS; Pickering AD; Gray JA; Jones SH; Abrahams S; Hemsley DR
    J Psychopharmacol; 1997; 11(4):301-11. PubMed ID: 9443517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm.
    Ellenbroek BA; Knobbout DA; Cools AR
    Psychopharmacology (Berl); 1997 Jan; 129(2):112-20. PubMed ID: 9040116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of d-amphetamine on the temporal control of operant responding in rats during a preshock stimulus.
    Sanger DJ; Blackman DE
    J Exp Anal Behav; 1976 Nov; 26(3):369-78. PubMed ID: 1003072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.